BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6205806)

  • 1. The biology of malignant gliomas--a comprehensive survey.
    McComb RD; Bigner DD
    Clin Neuropathol; 1984; 3(3):93-106. PubMed ID: 6205806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against "basic fibroblast growth factor"].
    Nemati MN; Stan AC; Pütz KM; Pietsch T; Walter GF; Dietz H
    Zentralbl Neurochir; 1996; 57(1):12-9. PubMed ID: 8900894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of VEGF expression and related neo-angiogenesis in childhood high-grade gliomas: implications for anti-angiogenic anti-neoplastic therapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2006; 20(4):511-8. PubMed ID: 16900782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
    Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
    Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
    Khalanskiĭ AS; Shevchenko GM; Berezin VA
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
    Grobben B; De Deyn PP; Slegers H
    Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical localization of fibronectin, laminin and fibronectin-receptor in human malignant gliomas--in relation to tumor invasion].
    Higuchi M; Ohnishi T; Arita N; Hiraga S; Iwasaki H; Mori S; Hayakawa T
    No To Shinkei; 1991 Jan; 43(1):17-23. PubMed ID: 1828988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids.
    Guerin C; Wolff JE; Laterra J; Drewes LR; Brem H; Goldstein GW
    Ann Neurol; 1992 May; 31(5):481-7. PubMed ID: 1596083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of antigenic expression of human glioma cells.
    McKeever PE; Davenport RD; Shakui P
    Crit Rev Neurobiol; 1991; 6(2):119-47. PubMed ID: 1934088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.